Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
NNX 0.035 +0.0% ABX 51.92 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.70 +9.1% TUNG 1.74 +3.0% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.49 +0.9% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.305 −4.7% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.92 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.70 +9.1% TUNG 1.74 +3.0% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.49 +0.9% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.305 −4.7% DEX 0.390 +1.3% WMS 0.040 +0.0%
Financings Routine +

Custom Health Holdings Inc. to Commence Trading on the Toronto Stock Exchange

Custom Health Secures TSX Listing and $60M in Financing to Scale Remote Care Platform

By The Northwire Desk — AI Analysis Jun 22, 2026 · 17:46 CHLT NaN
Executive Summary
  • Custom Health Holdings Inc. received final TSX approval for its common shares to commence trading on June 24, 2026.
  • The listing follows the completion of a plan of arrangement to acquire 100% of Custom Delaware.
  • The company is no longer classified as a "venture issuer" under NI 51-102.
  • Multiple financing arrangements were executed totaling up to US$50 million in convertible/promissory notes and C$10 million in credit facilities, accompanied by warrant issuances.
  • Specific facilities include Funicular senior secured convertible notes (up to US$20M), Yorkville promissory notes (up to US$15M), 102 Saskatchewan unsecured credit facility (up to US$15M), and FairCap secured credit facility (C$10M).
  • Warrants carry exercise prices tied to VWAP or a US$8.00 floor, with coverage ratios ranging from 50% to 100% of principal.
Material Impact
  • The announcement represents a standard corporate evolution milestone rather than an unexpected operational or financial breakthrough.
  • The TSX listing and venture issuer status change improve capital market access, liquidity, and public profile, which are structurally positive for a growth-stage healthcare technology company.
  • The $60 million in debt/equity-linked financing provides immediate liquidity to fund acquisitions, working capital, and integration of Custom Delaware.
  • However, the financing structure introduces significant potential dilution through warrants and convertible notes, alongside fixed interest obligations (e.g., 12% annual interest on the Saskatchewan facility).
  • No immediate revenue, margin, or cash flow impact is disclosed; the capital is earmarked for strategic deployment rather than current operations.
CHLT · Price
Company Overview
  • Custom Health Holdings Inc. operates in the healthcare technology sector, focusing on technology-enabled medication management, pharmacy services, and remote clinical care.
  • The recent plan of arrangement consolidates 100% ownership of Custom Delaware, suggesting a vertical or horizontal integration within the remote care and pharmacy management space.
  • Transitioning to a TSX-listed, non-venture issuer status positions the company to access broader institutional capital and pursue larger-scale acquisitions or partnerships.
Read the original news release →